The Memo | Special Edition: Medtech Trailblazers Headed to LSI Asia ‘25

As we gear up for LSI Asia ‘25 this June in Singapore, we’re spotlighting six standout innovators previously featured in The Memo—each of whom will be taking the stage to share the latest updates on their mission, technology, and milestones. This special edition recap brings their stories together in one place and gives you a preview of what to expect at LSI Asia ‘25.

Scout | Reinventing Home Diagnostics

Scout, led by Co-Founder and CEO Alex Jiao, is reimagining the way patients manage their health—starting at home. Their user-friendly, low-cost diagnostic device pairs with a mobile app and disposable test kits to deliver fast, reliable results for STIs and respiratory conditions, with follow-up care built into the experience.

“The goal is to create a new testing paradigm,” Jiao said. “Rather than driving to a clinic, waiting, and returning for results and treatment, you can test at home and immediately be connected to follow-up care through an app.”

The company’s at-home respiratory and STI panels are expected to enter clinical trials in 2025, supported by organizations like Flu Lab and CARB-X. Backed by data from their FDA EUA-approved COVID-19 test, Scout is preparing for a Series A to scale access to care.

NousQ | Revolutionizing Ear Tube Insertion

Founder and CEO Lynne Lim launched NousQ with a bold vision: to make ear tube surgery simpler and more accessible for patients in both developed and resource-limited settings. 

CLiKX, the company’s robotic handheld device, delivers ear tubes with a single click, reducing the need for a fully equipped operating room, general anesthesia, and a surgical microscope.

“It’s faster and less painful than receiving a vaccination,” Lim shared. “Some adults don’t even need local anesthesia.”

With 100% safety and over 95% success rates in ASEAN trials, the company is targeting regulatory approval in Singapore and preparing for U.S. pivotal trials. Lim’s drive to democratize care began with a humanitarian mission to Cambodia, where the lack of access to surgical infrastructure sparked the idea behind CLiKX.

InkSpace Imaging | Transforming MRI with Patient-Centered Innovation

Led by President and CEO Peter Fischer, InkSpace Imaging is making MRI scans more comfortable and efficient with ultralight, flexible coils. Initially developed for children, these body-conforming coils are now FDA-cleared for adult use and compatible with GE, Siemens, and Philips systems.

“We’re advancing MRI into the 21st century,” Fischer said. “Our coils snap-fit to the body, enabling anatomically optimized imaging without the discomfort or inefficiencies of rigid coils.”

InkSpace Imaging is seeing rapid commercial traction, strong KOL support, and revenue momentum. As the company develops additional coils for pediatrics, women’s health, oncology, and veterinary use, its commitment to patient-first innovation continues to reshape the MRI experience.

Wellumio | Revolutionizing Stroke Care with Portable Magnetic Resonance Technology

Wellumio’s Co-Founder and CEO, Shieak Tzeng, knows firsthand the consequences of delayed stroke care. That’s why he’s leading the charge to bring magnetic resonance-based stroke diagnostics directly to the bedside. The company’s portable scanner uses pulse gradient-free mapping to deliver fast, high-quality neuroimaging without the infrastructure demands of traditional MRI.

“In stroke care, the golden hour is everything,” Tzeng said. However, the reality is that the current healthcare system simply isn’t built for the kind of rapid diagnosis and intervention that stroke care demands.

Wellumio is currently conducting a first-in-human feasibility trial in Australia and preparing to activate its first U.S. site in 2025. Most recently, Wellumio signed a Memorandum of Understanding with Nicolab to explore integrating its Axana scanner with Nicolab’s AI-powered StrokeViewer platform. With FDA breakthrough designation on the horizon and a U.S.-based team in place, the company is poised to deliver faster stroke diagnosis and better outcomes—no matter where patients are treated.

Tensor Surgical | Redefining Orthopedic Soft Tissue Repair with Anchorless Innovation

President and CEO Justin Anderson has built a career in challenging surgical orthodoxy—and now he’s doing it again at Tensor Surgical. The company’s TransOs Tunneler soft tissue repair system eliminates the need for suture anchors in rotator cuff repair, lowering costs, preserving native bone, and improving healing.

“The shift away from anchors is not theoretical—it’s a real, worldwide trend already underway,” Anderson said. “By passing savings directly to our customers, Tensor Surgical is expanding its global market reach and making top-tier care accessible across geographies.”

With over 10,000 successful procedures, national contracts in place, and AI-powered systems driving efficiency, Tensor is scaling up and cementing its position as a disruptive force in value-based orthopedic care.

Solenic Medical | Transforming PJI Treatment with Magnetic Precision

CEO and Chairman James Lancaster is leading Solenic Medical in the fight against prosthetic joint infections (PJIs)—a serious and costly complication of orthopedic implants. Using alternating magnetic fields to generate targeted heat on metal implants, Solenic disrupts bacterial biofilms noninvasively and synergistically with antibiotics.

“We’re the only option that treats these infections without surgery,” Lancaster said. “And sadly, the consequences we’re working to avoid—amputation or even death—happen more often than they should.”

Solenic has already treated its first patient in an early feasibility trial, earned FDA Breakthrough Device Designation, and is preparing for a pivotal knee trial by the end of 2025. The company is also expanding its footprint across Asia, with manufacturing in Taiwan and growing clinical interest from Singapore, Japan, and South Korea.

See Them Live at LSI Asia ’25

All six of these pioneering medtech companies will take the stage at LSI Asia ’25 this June in Singapore. From transforming diagnostic access and surgical procedures to disrupting stroke care and PJI treatment, these leaders are changing what’s possible for patients worldwide.

Want a front-row seat to what’s next in medtech? Join us at LSI Asia ‘25 and hear directly from the minds behind these breakthrough innovations.